Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care
Young infants have a more severe and complex hospital course with RSV hospitalisation compared with hospitalisation with other respiratory viruses and should be prioritised for prevention measures such as the single-dose monoclonal antibody, nirsevimab.
Authors
- Huong Thi Le (ORCID: https://orcid.org/0000-0002-2913-7065)
- Hannah C. Moore (ORCID: https://orcid.org/0000-0001-6434-8290)
- Peter Richmond (ORCID: https://orcid.org/0000-0001-5796-735X)
- Avram Levy (ORCID: https://orcid.org/0000-0002-0934-2387)
- Kathryn Glass (ORCID: https://orcid.org/0000-0001-5905-1310)
- Mohinder Sarna (ORCID: https://orcid.org/0000-0002-2448-1588)
- Belaynew Wasie Taye (ORCID: https://orcid.org/0000-0003-2659-1059)
Institutions
- Australian National University (AU)
- The Kids Research Institute Australia (AU)
- The University of Western Australia (AU)
- Curtin University (AU)
- Princess Margaret Hospital for Children (AU)
- Pathwest Laboratory Medicine (AU)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1136/bmjresp-2024-002613
- Citations
- 8
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 3.09
Funders
- Stan Perron Charitable Foundation
- Merck Sharp and Dohme